Discordance between 2D and 4D flow in the assessment of pulmonary regurgitation severity: a right ventricular remodeling follow-up study.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 12 08 2022
accepted: 06 02 2023
revised: 06 12 2022
medline: 10 7 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Pulmonary regurgitation (PR) is common in adult congenital heart disease (ACHD). 2D phase contrast MRI is the reference method for the quantification of PR and helps in the decision of pulmonary valve replacement (PVR). 4D flow MRI can be an alternative method to estimate PR but more validation is still needed. Our purpose was to compare 2D and 4D flow in PR quantification using the degree of right ventricular remodeling after PVR as the reference standard. In 30 adult patients with a pulmonary valve disease recruited between 2015 and 2018, PR was assessed using both 2D and 4D flow. Based on the clinical standard of care, 22 underwent PVR. The pre PVR estimate of PR was compared using the post-operative decrease in right ventricle end-diastolic volume on follow-up exam as reference. In the overall cohort, regurgitant volume (Rvol) and regurgitant fraction (RF) of PR measured by 2D and 4D flow were well correlated but with moderate agreement in the overall cohort (r = 0.90, mean diff.  -14 ± 12.5 mL; and r = 0.72, mean diff.  -15 ± 13%; all p < 0.0001). Correlations between Rvol estimates and right ventricle end-diastolic volume decrease after PVR was higher with 4D flow (r = 0.80, p < 0.0001) than with 2D flow (r = 0.72, p < 0.0001). In ACHD, PR quantification from 4D flow better predicts post-PVR right ventricle remodeling than that from 2D flow. Further studies are needed to evaluate the added value of this 4D flow quantification for guiding replacement decision. • Using 4D flow MRI allows a better quantification of pulmonary regurgitation in adult congenital heart disease than 2D flow when taking right ventricle remodeling after pulmonary valve replacement as a reference. • A plane positioned perpendicular to the ejected flow volume as allowed by 4D flow provides better results to estimate pulmonary regurgitation.

Identifiants

pubmed: 36905468
doi: 10.1007/s00330-023-09502-6
pii: 10.1007/s00330-023-09502-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5455-5464

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Radiology.

Références

Fratz S, Chung T, Greil GF et al (2013) Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson 15(1):51
Valente AM, Cook S, Festa P et al (2014) Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 27:111–141
doi: 10.1016/j.echo.2013.11.009 pubmed: 24468055
Stout KK, Daniels CJ, Aboulhosn JA et al (2019) 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary. J Am Coll Cardiol 73:1494–1563
doi: 10.1016/j.jacc.2018.08.1028 pubmed: 30121240
Geva T, Mulder B, Gauvreau K et al (2018) Preoperative predictors of death and sustained ventricular tachycardia after pulmonary valve replacement in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Circulation 138:2106–2115
doi: 10.1161/CIRCULATIONAHA.118.034740 pubmed: 30030416
Oosterhof T, van Straten A, Vliegen HW et al (2007) Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116:545–551
doi: 10.1161/CIRCULATIONAHA.106.659664 pubmed: 17620511
Bokma JP, Winter MM, Oosterhof T et al (2016) Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J 37:829–835
Hsiao A, Lustig M, Alley MT et al (2012) Evaluation of valvular insufficiency and shunts with parallel-imaging compressed-sensing 4D phase-contrast MR imaging with stereoscopic 3D velocity-fusion volume-rendered visualization. Radiology 265:87–95
doi: 10.1148/radiol.12120055 pubmed: 22923717 pmcid: 3447178
Vasanawala SS, Hanneman K, Alley MT, Hsiao A (2015) Congenital heart disease assessment with 4D flow MRI. J Magn Reson Imaging 42:870–886
doi: 10.1002/jmri.24856 pubmed: 25708923
Fredriksson A, Trzebiatowska-Krzynska A, Dyverfeldt P et al (2018) Turbulent kinetic energy in the right ventricle: potential MR marker for risk stratification of adults with repaired tetralogy of Fallot. J Magn Reson Imaging 47:1043–1053
doi: 10.1002/jmri.25830 pubmed: 28766919
Sjoberg P, Bidhult S, Bock J et al (2018) Disturbed left and right ventricular kinetic energy in patients with repaired tetralogy of Fallot: pathophysiological insights using 4D-flow MRI. Eur Radiol 28:4066–4076
doi: 10.1007/s00330-018-5385-3 pubmed: 29666995 pmcid: 6132722
Robinson JD, Rose MJ, Joh M et al (2019) 4-D flow magnetic-resonance-imaging-derived energetic biomarkers are abnormal in children with repaired tetralogy of Fallot and associated with disease severity. Pediatr Radiol 49:308–317
doi: 10.1007/s00247-018-4312-8 pubmed: 30506329
Zhao X, Hu L, Leng S et al (2022) Ventricular flow analysis and its association with exertional capacity in repaired tetralogy of Fallot: 4D flow cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 24:4. https://doi.org/10.1186/s12968-021-00832-2
doi: 10.1186/s12968-021-00832-2 pubmed: 34980199 pmcid: 8722058
Bock J, Toger J, Bidhult S et al (2019) Validation and reproducibility of cardiovascular 4D-flow MRI from two vendors using 2 x 2 parallel imaging acceleration in pulsatile flow phantom and in vivo with and without respiratory gating. Acta Radiol 60:327–337
doi: 10.1177/0284185118784981 pubmed: 30479136
Brix L, Ringgaard S, Rasmusson A et al (2009) Three dimensional three component whole heart cardiovascular magnetic resonance velocity mapping: comparison of flow measurements from 3D and 2D acquisitions. J Cardiovasc Magn Reson 11:3. https://doi.org/10.1186/1532-429X-11-3
doi: 10.1186/1532-429X-11-3 pubmed: 19232119 pmcid: 2649114
Bollache E, van Ooij P, Powell A et al (2016) Comparison of 4D flow and 2D velocity-encoded phase contrast MRI sequences for the evaluation of aortic hemodynamics. Int J Cardiovasc Imaging 32:1529–1541
doi: 10.1007/s10554-016-0938-5 pubmed: 27435230 pmcid: 5096729
Tariq U, Hsiao A, Alley M et al (2013) Venous and arterial flow quantification are equally accurate and precise with parallel imaging compressed sensing 4D phase contrast MRI. J Magn Reson Imaging 37:1419–1426
doi: 10.1002/jmri.23936 pubmed: 23172846
Kamphuis VP, Roest AAW, Ajmone Marsan N et al (2019) Automated cardiac valve tracking for flow quantification with four-dimensional flow MRI. Radiology 290:70–78
doi: 10.1148/radiol.2018180807 pubmed: 30375924
Isorni MA, Martins D, Ben Moussa N et al (2020) 4D flow MRI versus conventional 2D for measuring pulmonary flow after Tetralogy of Fallot repair. Int J Cardiol 300:132–136
doi: 10.1016/j.ijcard.2019.10.030 pubmed: 31676117
Jacobs KG, Chan FP, Cheng JY et al (2020) 4D flow vs. 2D cardiac MRI for the evaluation of pulmonary regurgitation and ventricular volume in repaired tetralogy of Fallot: a retrospective case control study. Int J Cardiovasc Imaging 36:657–669
doi: 10.1007/s10554-019-01751-1 pubmed: 31894524 pmcid: 8018898
Chelu RG, Wanambiro KW, Hsiao A et al (2016) Cloud-processed 4D CMR flow imaging for pulmonary flow quantification. Eur J Radiol 85:1849–1856
doi: 10.1016/j.ejrad.2016.07.018 pubmed: 27666627
Uretsky S, Gillam L, Lang R et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity. J Am Coll Cardiol 65:1078–1088
doi: 10.1016/j.jacc.2014.12.047 pubmed: 25790878
Baumgartner H, De Backer J, Babu-Narayan SV et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42:563–645
doi: 10.1093/eurheartj/ehaa554 pubmed: 32860028
Endorsed by the Association for European Paediatric Cardiology (AEPC), Authors/Task Force Members, Baumgartner H et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): the Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 31:2915–2957
Kilner PJ, Geva T, Kaemmerer H et al (2010) Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 31:794
doi: 10.1093/eurheartj/ehp586 pubmed: 20067914 pmcid: 2848324
Nayak KS, Nielsen J-F, Bernstein MA et al (2015) Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson 17:71. https://doi.org/10.1186/s12968-015-0172-7
doi: 10.1186/s12968-015-0172-7 pubmed: 26254979 pmcid: 4529988
Craiem D, Pascaner AF, Casciaro ME et al (2019) Automatic correction of background phase offset in 4D-flow of great vessels and of the heart in MRI using a third-order surface model. MAGMA 32:629–642
doi: 10.1007/s10334-019-00765-z pubmed: 31230182
Jones TK, Rome JJ, Armstrong AK et al (2016) Transcatheter pulmonary valve replacement reduces tricuspid regurgitation in patients with right ventricular volume/pressure overload. J Am Coll Cardiol 68:1525–1535
doi: 10.1016/j.jacc.2016.07.734 pubmed: 27687194
Alvarez A, Martinez V, Pizarro G et al (2020) Clinical use of 4D flow MRI for quantification of aortic regurgitation. Open Heart 7:e001158. https://doi.org/10.1136/openhrt-2019-001158
Casciaro ME, Pascaner AF, Guilenea FN et al (2021) 4D flow MRI: impact of region of interest size, angulation and spatial resolution on aortic flow assessment. Physiol Meas 42. https://doi.org/10.1088/1361-6579/abe525
Dyverfeldt P, Bissell M, Barker AJ et al (2015) 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 17:72. https://doi.org/10.1186/s12968-015-0174-5
doi: 10.1186/s12968-015-0174-5 pubmed: 26257141 pmcid: 4530492
Juffermans JF, Minderhoud SCS, Wittgren J et al (2021) Multicenter consistency assessment of valvular flow quantification with automated valve tracking in 4D flow CMR. JACC Cardiovasc Imaging 14:1354–1366
doi: 10.1016/j.jcmg.2020.12.014 pubmed: 33582060
Zoghbi WA, Adams D, Bonow RO et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation. J Am Soc Echocardiogr 30:303–371
doi: 10.1016/j.echo.2017.01.007 pubmed: 28314623
Wald RM, Redington AN, Pereira A et al (2008) Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? Eur Heart J 30:356–361
doi: 10.1093/eurheartj/ehn595
Śpiewak M, Biernacka EK, Małek ŁA et al (2011) Quantitative assessment of pulmonary regurgitation in patients with and without right ventricular tract obstruction. Eur J Radiol 80:e164–e168
doi: 10.1016/j.ejrad.2010.07.009 pubmed: 20696542

Auteurs

Gilles Soulat (G)

Université Paris cité, PARCC (Paris-Cardiovascular Research Center), INSERM 970, 20 rue Leblanc, F-75015, Paris, France. gilles.soulat@aphp.fr.
Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France. gilles.soulat@aphp.fr.

Yousef Alattar (Y)

Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Magalie Ladouceur (M)

Université Paris cité, PARCC (Paris-Cardiovascular Research Center), INSERM 970, 20 rue Leblanc, F-75015, Paris, France.
Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Damian Craiem (D)

Instituto de Medicina Traslacional, Trasplante y Bioingeniería (IMeTTyB), Universidad Favaloro-CONICET, Buenos Aires, Argentina.

Ariel Pascaner (A)

Instituto de Medicina Traslacional, Trasplante y Bioingeniería (IMeTTyB), Universidad Favaloro-CONICET, Buenos Aires, Argentina.

Umit Gencer (U)

Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Sophie Malekzadeh-Milani (S)

Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Laurence Iserin (L)

Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Clement Karsenty (C)

Université Paris cité, PARCC (Paris-Cardiovascular Research Center), INSERM 970, 20 rue Leblanc, F-75015, Paris, France.
Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Elie Mousseaux (E)

Université Paris cité, PARCC (Paris-Cardiovascular Research Center), INSERM 970, 20 rue Leblanc, F-75015, Paris, France.
Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH